TerminatedNot Applicable

Evaluation of Renal Function in Subjects Who Had Undergone Cardiac Surgery

Stopped: Study terminated early due to program discontinuation.

United States16 participantsStarted 2020-02-21

Plain-language summary

To evaluate the differences between serum cystatin C based estimated glomerular filtration rate (eGFRcys), serum creatinine based eGFR (eGFRcreat) and measured glomerular filtration rate (mGFR) in subjects at high risk for acute kidney injury (AKI) approximately 90 days following cardiac surgery

Who can participate

Age range45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Reduced renal function
✓. Diabetes with ongoing insulin treatment
✓. Albuminuria

What they're measuring

Correlation between eGFR and mGFR

Timeframe: at 90 days post cardiac surgery

Trial details

NCT IDNCT04654221

SponsorQuark Pharmaceuticals

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2021-02-25

View on ClinicalTrials.gov More Cardiac Surgery trials